Cargando…
Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021887/ https://www.ncbi.nlm.nih.gov/pubmed/31823214 http://dx.doi.org/10.1007/s40744-019-00187-2 |
| _version_ | 1783497961147203584 |
|---|---|
| author | van Leeuwen, Kevin D. B. Bohnen, Arthur M. |
| author_facet | van Leeuwen, Kevin D. B. Bohnen, Arthur M. |
| author_sort | van Leeuwen, Kevin D. B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7021887 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70218872020-02-28 Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” van Leeuwen, Kevin D. B. Bohnen, Arthur M. Rheumatol Ther Letter Springer Healthcare 2019-12-10 /pmc/articles/PMC7021887/ /pubmed/31823214 http://dx.doi.org/10.1007/s40744-019-00187-2 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter van Leeuwen, Kevin D. B. Bohnen, Arthur M. Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title | Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title_full | Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title_fullStr | Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title_full_unstemmed | Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title_short | Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout” |
| title_sort | comment on “a randomized, double-blind, non-inferiority study of febuxostat versus allopurinol in hyperuricemic chinese subjects with or without gout” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021887/ https://www.ncbi.nlm.nih.gov/pubmed/31823214 http://dx.doi.org/10.1007/s40744-019-00187-2 |
| work_keys_str_mv | AT vanleeuwenkevindb commentonarandomizeddoubleblindnoninferioritystudyoffebuxostatversusallopurinolinhyperuricemicchinesesubjectswithorwithoutgout AT bohnenarthurm commentonarandomizeddoubleblindnoninferioritystudyoffebuxostatversusallopurinolinhyperuricemicchinesesubjectswithorwithoutgout |